​

Abeona Therapeutics Ownership | Who Owns Abeona Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Abeona Therapeutics Ownership Summary

Abeona Therapeutics is owned by 5.18% insiders, and 94.81% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.68% of its assets in Abeona Therapeutics shares.

ABEO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAbeona Therapeutics-5.18%94.81%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-2,350---1---
Sep 30, 20222-94.44%153,702-99.26%21.16%--100.00%2-60.00%
Jun 30, 202236-26.53%20,889,690-35.97%142.84%11-31.25%5-66.67%
Mar 31, 2022494.26%32,623,572-20.40%221.30%16-27.27%1525.00%
Dec 31, 202147-16.07%40,985,64961.98%416.24%2222.22%12-36.84%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.53M2.68%-
Vanguard US Total Market Shares ETF1.23M2.53%-
iShares Russell 2000 ETF1.11M1.94%9.31K
Kennedy Micro Cap874.59K1.53%149.62K
abrdn Life Sciences Investors616.41K1.12%-
Vanguard Institutional Extnd Mkt Idx Tr581.19K1.02%20.60K
Simplify Propel Opportunities ETF500.34K0.88%-
Fidelity Small Cap Index431.58K0.76%5.46K
Kennedy Micro Cap Opportunities387.03K0.68%64.31K
iShares Russell 2000 Growth ETF379.58K0.67%35.37K

Recent Insider Transactions

DateNameRoleActivityValue
May 11, 2026Vasanthavada Madhav Chief Commercial OfficerSell$33.07K
Mar 31, 2026Seshadri Vishwas Chief Executive OfficerSell$131.48K
Mar 16, 2026Vazzano Joseph Walter Chief Financial OfficerSell$3.74K
Feb 02, 2026Silverstein Christine Berni-Sell$102.17K
Feb 02, 2026Wuchterl Donald A.-Sell$75.41K

Insider Transactions Trends

DateBuySell
2026 Q2-1
2026 Q1-12
2025 Q4-3
2025 Q3-15
2025 Q2-5

ABEO Ownership FAQ

Who Owns Abeona Therapeutics?

Abeona Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 5.18% insiders and 94.82% retail investors. The average institutional ownership in Abeona Therapeutics's industry, Biotech Stocks , is 382.13%, which Abeona Therapeutics falls below.

Does Blackrock own Abeona Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Abeona Therapeutics.

Who is the top mutual fund holder of Abeona Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Abeona Therapeutics shares, with 2.68% of its total shares outstanding invested in 1.53M Abeona Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools